Current Neuro-Oncology
Volume
26 Number 18
31 August 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 18, 31 August
Ghosh HS, Patel RV, Woodward E, Greenwald NF, Bhave VM, Maury EA,
Cello G, Hoffman SE, Li Y, Gupta H, Youssef G, Spurr LF, Vogelzang
J, Touat M, Dubois F, Cherniack AD, Guo X, Tavakol S, Cioffi G,
Lindeman NI, Ligon AH, Chiocca EA, Reardon DA, Wen PY, Meredith D,
Santagata S, Barnholtz-Sloan JS, Ligon KL, Beroukhim R, Bi WL.
Contemporary Prognostic Signatures and
Refined Risk Stratification of Gliomas: An Analysis of 4,400
Tumors.
Neuro
Oncol. 2024 Aug 21:noae164. doi:
10.1093/neuonc/noae164. PMID:
39164213. Observational study. ˍ
Ståhl P, Henoch I, Rydenhag B, Smits A, Ozanne A.
Living
with glioblastoma - the need for integrated support based on
experiences of chaos, loss of autonomy, and isolation in both
patients and their relatives.
Support
Care Cancer. 2024 Aug 21;32(9):599. doi:
10.1007/s00520-024-08801-y. PMID:
39167224. Observational study. ˍ
Wang JZ, Patil V, Landry AP, Gui C, Ajisebutu A, Liu J, Saarela O,
Pugh SL, Won M, Patel Z, Yakubov R, Kaloti R, Wilson C,
Cohen-Gadol A, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F,
Almiron Bonnin DA, Holland EC, Kruser TJ, Barnholtz-Sloan JS,
Sloan AE, Horbinski C, Chotai S, Chambless LB, Gao A, Rebchuk AD,
Makarenko S, Yip S, Sahm F, Maas SLN, Tsang DS; International
Consortium on Meningiomas (ICOM); Rogers CL, Aldape K, Nassiri F,
Zadeh G.
Molecular classification to
refine surgical and radiotherapeutic decision-making in
meningioma.
Nat
Med. 2024 Aug 21. doi:
10.1038/s41591-024-03167-4. PMID:
39169220. Observational study. ˍ
Zhou WT, Niu JH, Liao C, Ren SK, Ou YW, Liu W, Li CD, Gong J, Tian
YJ.
Visual deterioration outcomes
following optic pathway glioma treatment: a 12-year single
institution retrospective study.
J
Neurooncol. 2024 Aug 21. doi:
10.1007/s11060-024-04802-3. PMID:
39167244. Observational study˰
ˍ
Biedermann GB, Merrifield K, Lustgarten L.
Case
report: Safety of Tumor Treating Fields therapy with an
implantable cardiac pacemaker in a patient with glioblastoma.
Front
Oncol. 2024 Aug 22;14:1441146. doi:
10.3389/fonc.2024.1441146. PMID:
39239269. Case report. ˍ
Hassan J, Hyde C, Joiner M, Miller SR.
Complete
radiographic response after proton radiation therapy in the
re-irradiation of a diffuse high-grade glioma: A case report.
SAGE
Open Med Case Rep. 2024 Aug 22;12:2050313X241274218.
doi:
10.1177/2050313X241274218. PMID:
39185065. Case report. ˍ
Zhou Y, Jia P, Fang Y, Zhu W, Gong Y, Fan T, Yin J.
Comprehensive
understanding of the adverse effects associated with temozolomide:
a disproportionate analysis based on the FAERS database.
Front
Pharmacol. 2024 Aug 23;15:1437436. doi:
10.3389/fphar.2024.1437436. PMID:
39246656. Observational study. ˍ
Zemskova O, Yu NY, Leppert J, Löser A, Rades D.
Can
Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte
Ratio (NLR) Help Predict Outcomes of Patients With Recurrent
Glioblastoma?
In
Vivo. 2024 Aug 26;38(5):2341-2348. doi:
10.21873/invivo.13700. PMID:
39187342. Observational study. ˍ
Guo Y, Li Z, Parsels LA, Wang Z, Parsels JD, Dalvi A, The S, Hu N,
Valvo VM, Doherty R, Peterson E, Wang X, Venkataraman S, Agnihotri
S, Venneti S, Wahl DR, Green MD, Lawrence TS, Koschmann C, Morgan
MA, Zhang Q.
H3K27M
diffuse midline glioma is homologous recombination defective and
sensitized to radiotherapy and NK cell-mediated antitumor immunity
by PARP inhibition.
bioRxiv
[Preprint]. 2024 Aug 27:2024.08.26.609803. doi:
10.1101/2024.08.26.609803. PMID:
39253432. Laboratory investigation. ˍ
Hainfellner A, Borkovec M, Seebrecht L, Neuhauser M,
Roetzer-Pejrimovsky T, Greutter L, Surböck B, Hager-Seifert
A, Gorka-Vom Hof D, Urbanic-Purkart T, Stultschnig M, Cijan C,
Würtz F, Calabek-Wohinz B, Pichler J, Höllmüller I,
Leibetseder A, Weis S, Kleindienst W, Seiberl M, Bieler L, Hecker
C, Schwartz C, Iglseder S, Heugenhauser J, Nowosielski M, Thomé
C, Moser P, Hoffermann M, Loibnegger K, Dieckmann K, Tomschik M,
Widhalm G, Rössler K, Marosi C, Wöhrer A, Hainfellner
JA, Oberndorfer S.
Glioblastoma in the
real-world setting: patterns of care and outcome in the Austrian
population.
J
Neurooncol. 2024 Aug 27. doi:
10.1007/s11060-024-04808-x. PMID:
39192069. Observational study. ˍ
Cheng F, Lin HF, Liang XJ, Wu SY, Wu XF, Tu WF.
Evaluation
of Factors Influencing Postoperative Cognitive Dysfunction in
Patients After Cranial Tumor Surgery.
J Craniofac
Surg. 2024 Aug 28. doi:
10.1097/SCS.0000000000010546. PMID:
39194192. Observational study˰
ˍ
Gulino V, Brunasso L, Avallone C, Costa V, Adorno AA, Lombardo MC,
Tumbiolo S, Iacopino DG, Maugeri R.
Caregivers'
Perspective and Burden of The End-of-Life Phase of Patients With
Glioblastoma: A Multicenter Retrospective Study.
World
Neurosurg. 2024 Aug 28:S1878-8750(24)01482-7. doi:
10.1016/j.wneu.2024.08.114. PMID:
39214291. Observational study. ˍ
Holdhoff M, Ye X, Strowd RE, Nabors B, Walbert T, Lieberman FS,
Bagley SJ, Fiveash JB, Fisher JD, Desideri S, Surakus T,
Engelhardt M, Kaindl T, Lane HA, Litherland K, Grossman SA,
Kleinberg LR.
Lisavanbulin
(BAL101553), a novel microtubule inhibitor, plus radiation in
patients with newly diagnosed, MGMT promoter unmethylated
glioblastoma.
Neurooncol
Adv. 2024 Aug 28;6(1):vdae150. doi:
10.1093/noajnl/vdae150. PMID:
39371261. Interventional study. ˍ
*Watanabe T, Noto S, Natsumeda M, Kimura S, Ikarashi F, Tabata S,
Takano M, Tsukamoto Y, Oishi M.
Improvements
in activities of daily living among patients with brain tumors are
associated with age, baseline physical function, duration of
rehabilitation, and tumor recurrence but not type.
Int
J Rehabil Res. 2024 Aug 28. doi:
10.1097/MRR.0000000000000641. PMID:
39190364. Observational study˰
ˍ
Borges de Almeida G, Pascuzzo R, Mambrin F, Aquino D, Verri M,
Moscatelli M, Del Bene M, DiMeco F, Silvani A, Pollo B, Grisoli M,
Doniselli FM.
The Role of Amide Proton
Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor
Grading, Molecular Profile and Survival in Different Tumor
Components.
Cancers
(Basel). 2024 Aug 29;16(17):3014. doi:
10.3390/cancers16173014. PMID:
39272871. Observational study. ˍ
Ledford A, Rodriguez A, Lipinski L, Abad A, Fenstermaker R,
Edenfield J, Kanos C, Redjal N, Mansouri A, Zacharia B, Butowski
N, Liu J, Han SJ, Ziu M, Cohen AL, Fabiano AJ, Miles K, Rayner M,
Thompson J, Tollison K, Azimzadeh P, Holmes L, Gevaert M,
DesRochers TM.
Functional prediction
of response to therapy prior to therapeutic intervention is
associated with improved survival in patients with high-grade
glioma.
Sci
Rep. 2024 Aug 29;14(1):19474. doi:
10.1038/s41598-024-68801-0. PMID:
39198514. Observational study. ˍ
McConville C, Lastakchi S, Al Amri A, Ngoga D, Fayeye O,
Cruickshank G.
Local Delivery of
Irinotecan to Recurrent GBM Patients at Reoperation Offers a Safe
Route of Administration.
Cancers
(Basel). 2024 Aug 29;16(17):3008. doi:
10.3390/cancers16173008. PMID:
39272866. Observational study. ˍ
Aboubakr O, Moiraghi A, Elia A, Tauziede-Espariat A, Roux A,
Leclerc A, Planet M, Bedioui A, Simboli GA, Dhermain F, Parraga E,
Benevello C, Fathallah H, Muto J, Chrétien F, Dezamis E,
Oppenheim C, Varlet P, Zanello M, Pallud J.
Long-term
survivors in 976 supratentorial glioblastoma, IDH-wildtype
patients.
J
Neurosurg. 2024 Aug 30:1-13. doi:
10.3171/2024.5.JNS24393. PMID:
39213667. Observational study˰
ˍ
Agiananda F, Aninditha T, Sofyan HR, Savitri I, Karnasih A,
Puspaseruni PA, Putri CK.
AB068.
Psychiatric disorder in central nervous system tumor patients and
its related factors.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB068. doi:
10.21037/cco-24-ab068. PMID:
39295386. Observational study. ˍ
Bauman MMJ, Jusue-Torres I, White JJ, Bouchal SM, Hsu AR, Ha Y,
Pumford AD, Hong S, Riviere-Cazaux C, Wang K, Brown DA, Helal A,
Parney IF.
Presentation, surgical
outcome, and supplementary motor area syndrome risk of posterior
superior frontal gyrus tumors.
J
Neurosurg. 2024 Aug 30:1-12. doi:
10.3171/2024.5.JNS231850. PMID:
39213666. Observational study˰
ˍ
Chen Z, Guo C, Yang Q, Lin F, Hu W, Xi S, Zhang J, Jiang X, Li D,
Chen Y, Ke C, Zhou J, Zhou Z, Ceng S.
AB048.
Evidence of effectiveness of neoadjuvant camrelizumab and apatinib
in patients with recurrent high-grade gliomas.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB048. doi:
10.21037/cco-24-ab048. PMID:
39295366. Interventional study. ˍ
Humam N, Widodo D.
AB058. Giant
bilateral intraventricle ependymoma in pediatric patient with
essential tremor as a main symptom: a rare case report.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB058. doi:
10.21037/cco-24-ab058. PMID:
39295376. Case report. ˍ
Li C, Zhou W, Wang P, Ji P, Wang Y, Guo S, Zhai Y, Xu M, Wang L,
Feng F, Liu J.
Prognostic
Factors for Patients With primary gliosarcoma: A Single-Center
Retrospective Study.
World
Neurosurg. 2024 Aug 30:S1878-8750(24)01497-9. doi:
10.1016/j.wneu.2024.08.128. PMID:
39216722. Observational study˰
ˍ
*Li D, Xu P, Yang Q, Guo C, Xi S, Sai K, Chen Z.
AB047.
Searching for factors relating to long-term survivors of
glioblastoma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB047. doi:
10.21037/cco-24-ab047. PMID:
39295365. Observational study. ˍ
Ott K, Cepeda S, Hartmann D, Kramer F, Müller D.
Predicting
Overall Survival of Glioblastoma Patients Using Deep Learning
Classification Based on MRIs.
Stud
Health Technol Inform. 2024 Aug 30;317:356-365. doi:
10.3233/SHTI240878. PMID:
39234740. Observational study. ˍ
Satragno C, Schiavetti I, Cella E, Picichè F, Falcitano L,
Resaz M, Truffelli M, Caneva S, Mattioli P, Esposito D, Ginulla A,
Scaffidi C, Fiaschi P, D'Andrea A, Bianconi A, Zona G, Barletta L,
Roccatagliata L, Castellan L, Morbelli S, Bauckneht M, Donegani I,
Nozza P, Arnaldi D, Vidano G, Gianelli F, Barra S, Bennicelli E,
Belgioia L; disease management team on Neuroncology of IRCCS
Ospedale Policlinico San Martino.
Systemic
inflammatory markers and volume of enhancing tissue on
post-contrast T1w MRI images in differentiating true tumor
progression from pseudoprogression in high-grade glioma.
Clin
Transl Radiat
Oncol. 2024 Aug 30;49:100849. doi:
10.1016/j.ctro.2024.100849. PMID:
39318678. Observational study. ˍ
Sonoda Y, Sekino Y, Mizusawa J, Shibahara I, Sasaki K, Sekita T,
Ichikawa M, Igaki H, Kinoshita M, Shibahara J, Ichimura K, Arakawa
Y, Fukuda H, Narita Y.
AB012. A phase
III randomized trial of gross total resection versus possible
resection of fluid-attenuated inversion recovery (FLAIR)
hyperintensity lesion on magnetic resonance image for newly
diagnosed supratentorial glioblastoma (JCOG2209).
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB012. doi:
10.21037/cco-24-ab012. PMID:
39295330. Interventional study. ˍ
Spencer D, Bonner ER, Tor-Díez
C, Liu X, Bougher K, Prasad R, Gordish-Dressman H, Eze A, Packer
RJ, Nazarian J, Linguraru MG, Bornhorst M.
Tumor
volume
features predict survival outcomes for patients diagnosed with
diffuse intrinsic
pontine glioma.
Neurooncol
Adv. 2024 Aug
30;6(1):vdae151. doi:
10.1093/noajnl/vdae151. PMID:
39434924. Observational study. ˍ
Takada S, Takeuchi Y, Makino Y, Yamamoto E, Sano N, Tanji M,
Mineharu Y, Arakawa Y.
AB014. The
accurate classification of high-grade glioma, IDH-wildtype, is
based on methylation profiling: a case report.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB014. doi:
10.21037/cco-24-ab014. PMID:
39295332. Case report. ˍ
Tanaka T, Tamura R, Takei J, Yamamoto Y, Akasaki Y, Murayama Y,
Miyake K, Sasaki H.
AB052. A
multicenter prospective exploratory phase II study of neoadjuvant
bevacizumab for newly diagnosed malignant glioma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB052. doi:
10.21037/cco-24-ab052. PMID:
39295370. Interventional study. ˍ
Umemura Y, Clarke N, Al-Holou W, Elaimy A, Scott A, Leung D, Kim
M, Ferris S, Thomas J, Heth J, Schipper M, Suresh K, Lawrence T,
Wahl D.
AB036. Targeting glioblastoma
de-novo purine metabolism to overcome chemoradiation resistance:
an interim result of phase 0/1 clinical trial in newly diagnosed
and recurrent glioblastoma.
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB036. doi:
10.21037/cco-24-ab036. PMID:
39295354. Interventional study. ˍ
Zhang H, Li J, Wan X, Liu Z.
A
nomogram to predict cancer-specific mortality in adult patients
with malignant meningioma: a competing risk analysis.
Discov
Oncol. 2024 Aug 31;15(1):394. doi:
10.1007/s12672-024-01263-y. PMID:
39217259. Observational study. ˍ